Abiopharma

🔍 Falkenstein Russell (Executive)

Company: Katapult Holdings, Inc. (KPLT)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 224,100 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 224,100.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 393,082 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 617,182.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Received in exchange for the contribution and assignment of 95 Class B Units of Aaron's MIP Holdings, LLC to the Issuer in exchange for shares the Issuer's common stock in connection with the mergers of Aaron's Intermediate Holdco, Inc. and CCF Holdings, LLC into the Issuer (the "Mergers"). On the effective date of the Mergers, the closing price of the Issuer's common stock was $8.00 per share.
• F2: Reflects an award of restricted stock units pursuant ("RSUs") as part of the Mergers that will vest over two years, with 25% of the RSUs vesting on February 11, 2027, and the remaining RSUs vesting thereafter in three substantially equal semi-annual installments on the 11th of each of February and August of each year, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date.